This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2014 Jan;2(1):6-7.

doi: 10.1016/S2213-8587(13)70107-4. Epub 2013 Oct 18.

Acarbose: an alternative to metformin for first-line treatment in type 2 diabetes?

Ronald C W Ma¹

Affiliations

Affiliation

¹ Department of Medicine and Therapeutics, Prince of Wales Hospital, Hong Kong Special Administrative Region, China; The Li Ka Shing Institute of Health Sciences, Hong Kong Special Administrative Region, China; Hong Kong Institute of Diabetes and Obesity, Chinese University of Hong Kong, Hong Kong Special Administrative Region, China. Electronic address: rcwma@cuhk.edu.hk.

PMID: 24622656
DOI: 10.1016/S2213-8587(13)70107-4

Comment

Acarbose: an alternative to metformin for first-line treatment in type 2 diabetes?

Ronald C W Ma. Lancet Diabetes Endocrinol. 2014 Jan.

. 2014 Jan;2(1):6-7.

doi: 10.1016/S2213-8587(13)70107-4. Epub 2013 Oct 18.

Author

Ronald C W Ma¹

Affiliation

¹ Department of Medicine and Therapeutics, Prince of Wales Hospital, Hong Kong Special Administrative Region, China; The Li Ka Shing Institute of Health Sciences, Hong Kong Special Administrative Region, China; Hong Kong Institute of Diabetes and Obesity, Chinese University of Hong Kong, Hong Kong Special Administrative Region, China. Electronic address: rcwma@cuhk.edu.hk.

PMID: 24622656
DOI: 10.1016/S2213-8587(13)70107-4

No abstract available

PubMed Disclaimer

Comment on

Acarbose compared with metformin as initial therapy in patients with newly diagnosed type 2 diabetes: an open-label, non-inferiority randomised trial.
Yang W, Liu J, Shan Z, Tian H, Zhou Z, Ji Q, Weng J, Jia W, Lu J, Liu J, Xu Y, Yang Z, Chen W. Yang W, et al. Lancet Diabetes Endocrinol. 2014 Jan;2(1):46-55. doi: 10.1016/S2213-8587(13)70021-4. Epub 2013 Oct 18. Lancet Diabetes Endocrinol. 2014. PMID: 24622668 Clinical Trial.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- scite Smart Citations
Medical
- ClinicalTrials.gov
- MedlinePlus Health Information